Publications by authors named "Mercedes Avedillo Ruidiaz"
Cancers (Basel)
November 2023
Article Synopsis
- Biliary tract tumours, such as those affecting the bile duct and gallbladder, are rare and typically diagnosed at advanced stages, leading to poor treatment options and a five-year survival rate below 20%.
- First-line chemotherapy using gemcitabine-cisplatin shows only modest effectiveness, prompting the need for better therapeutic strategies, with the ABC-06 trial presenting FOLFOX as the standard second-line therapy.
- While nal-IRI plus 5-FU/LV from the NIFTY trial shows promise, conflicting results from the NALIRICC trial and challenges in patient care highlight the need for more effective first-line treatments and ongoing research into tailored therapies.
